NURS 6531 Adele Spencer iHuman Management Plan Primary Diagnosis
NURS6531 Adele Spencer I Human Management Plan
Primary Diagnosis and ICD-10 code:
... [Show More] G35
Additional laboratory and diagnostic tests: Initial: Brain MRI, Cervical Spine MRI, Cerebrospinal Fluid (CSF) analysis, Anti-Neutrophil Cytoplasmic antibody (ANCA)
Additional labs: None
Consults: Patient will be referred to a neurologist and ophthalmologist. Return after 4-6 weeks for follow-up appointment.
Medication: HCTZ Medication Dalfampridine 10 mg by mouth daily Armodafinil 150 mg by mouth in the morning
Non-pharmacological management:
To manage weakness: Consider rehabilitation services for strength training and adaptive devices as needed Keep core body temperature down
Health Promotion: Exercise Maintain ideal body weight. Keep current with immunizations. Stop Smoking
Patient education: Take medication as prescribed. Educated on preventive health care, exercise, diet, lifestyle modifications, and avoidance of drug and alcohol abuse.
Disposition/follow-up instructions: Follow-up in 4-6 weeks post appointment with neurologist and ophthalmologist.
References:
This study source was downloaded by 100000827039679 from CourseHero.com on 08-15-2021 17:16:16 GMT -05:00 https://www.coursehero.com/file/74870593/Adele-Spencer-I-Human-Mangement-Plan-Nurs6531docx/
This study resource wasFinlayson, M., Akbar, N., Turpin, K., & Smyth, P. (2019). A multi-site randomized controlled trial of MS INFoRm, a fatigue self-management website for persons with multiple sclerosis: rationale and study protocol. BMC Neurology, 19(1), 142. Retrieved from https://doi-org.ezp.waldenulibrary.org/10.1186/s12883-019-1367-6
Ghahari, S., Forwell, S. J., Suto, M. J., & Morassaei, S. (2019). Multiple sclerosis selfmanagement model: Personal and contextual requirements for successful selfmanagement. Patient Education and Counseling, 102(5), 1013–1020. Retrieved from https://doi-org.ezp.waldenulibrary.org/10.1016/j.pec.2018.12.028
Kern, D. M., & Cepeda, M. S. (2020). Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States. BMC Neurology, 20(1), 1–8. Retrieved from https://doi-org.ezp.waldenulibrary.org/10.1186/s12883-020-01882-2
Li, P., Ladage, V. P., Berger, J., Chahin, S., Jhaveri, M., Geremakis, C., & Doshi, J. A. (2020). Disease-modifying therapy adherence and associated factors in a national sample of Medicare patients with multiple sclerosis. Value in Health, 23(3), 328–334. Retrieved from https://doi-org.ezp.waldenulibrary.org/10.1016/j.jval.2019.10.011
Maniscalco, G. T., et. al. (2020). First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study. Multiple Sclerosis and Related Disorders, 42. Retrieved from https://doi-org.ezp.waldenulibrary.org/10.1016/j.msard.2020.102059
This study source was downloaded by 100000827039679 from CourseHero.com on 08-15-2021 17:16:16 GMT -05:00 https://www.coursehero.com/file/74870593/Adele-Spencer-I-Human-Mangement-Plan-Nurs6531docx/
Powered by TCPDF (www.tcpdf.org)
This study resource [Show Less]